September 8, 2026
Tempus AI
Tempus AI raised $600 million in Series C funding to scale its AI-enhanced liquid biopsy platform for cancer recurrence detection.
- Round
- Series C
- Amount raised
- $600M
- Lead investor
- —
- Industry
- Biotechnology
- Headquarters
- —
- Employees
- 5,000 employees
- Website
- tempus.com
- View profile →
Source: Google Alerts